Close Menu

NEW YORK – Purveyors of genomics research tools were lining up at last week's SynBioBeta conference in San Francisco, to sell materials and assays used to engineer and analyze microbes that could produce goods and materials in a number of global markets.

Agilent, Illumina, Thermo Fisher Scientific, and Twist Bioscience were among the largest firms at this year's event, looking to engage with existing and potential customers who are trying to engineer biology — mainly microbes — to create new products in energy, materials, and agriculture.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.